Literature DB >> 3285295

Immunohistochemical detection of the neu protein in tissue sections of human breast tumors with amplified neu DNA.

M J van de Vijver1, W J Mooi, P Wisman, J L Peterse, R Nusse.   

Abstract

Amplification of the neu (or c-erbB-2 or HER) oncogene is relatively frequent in human breast carcinomas. We have raised a polyclonal rabbit serum in order to detect the neu protein product in tissue sections of tumors. This serum specifically reacted with a 185 kilodaltons neu protein in SKBR-3 cells, a mammary carcinoma cell line with amplified neu. Immunohistochemistry on paraffin-embedded sections of tumors in which the neu gene was amplified showed distinct membrane staining of groups of tumor cells. Sections of tumors with normal copy numbers of neu were negative. Lymph node metastases from tumors positive for neu overexpression also showed the membrane staining pattern, whereas lymph node metastases from tumors negative for neu staining never did. Neu amplification is thus associated with neu protein overproduction in tumors and lymph node metastases, and a routine antibody staining technique can discriminate a high level of neu protein expression from levels commonly present in tumors with normal neu copy numbers.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3285295

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  18 in total

1.  Negative autoregulation of the neu gene is mediated by a novel enhancer.

Authors:  X Y Zhao; M C Hung
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

2.  Multiple cis- and trans-acting elements involved in regulation of the neu gene.

Authors:  T C Suen; M C Hung
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

Review 3.  Role of HER2-neu as a prognostic factor for survival and relapse in pT1a-bN0M0 breast cancer: a systematic review of the literature with a pooled-analysis.

Authors:  F Petrelli; S Barni
Journal:  Med Oncol       Date:  2012-03-14       Impact factor: 3.064

Review 4.  The neu-protein and breast cancer.

Authors:  C R De Potter; A M Schelfhout
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

5.  Expression of the c-erbB-2 proto-oncogene product and nuclear DNA content in benign and malignant human breast parenchyma.

Authors:  H Schimmelpenning; E T Eriksson; U G Falkmer; E Azavedo; G Svane; G U Auer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

6.  Determination of a fragment of the c-erbB-2 translational product p185 in serum of breast cancer patients.

Authors:  B Kynast; L Binder; D Marx; B Zoll; H J Schmoll; M Oellerich; A Schauer
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

Review 7.  Genomic predictors of outcome and treatment response in breast cancer.

Authors:  Lara Dunn; Angela Demichele
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

8.  Neu proto-oncogene amplification and expression in ovarian adenocarcinoma cell lines.

Authors:  B L King; D Carter; H G Foellmer; B M Kacinski
Journal:  Am J Pathol       Date:  1992-01       Impact factor: 4.307

9.  Association of immunohistochemical p53 tumor suppressor gene protein overexpression with prognosis in highly proliferative human mammary adenocarcinomas.

Authors:  H Schimmelpenning; E T Eriksson; A Zetterberg; G U Auer
Journal:  World J Surg       Date:  1994 Nov-Dec       Impact factor: 3.352

Review 10.  Current molecular diagnostics of breast cancer and the potential incorporation of microRNA.

Authors:  Christine K Zoon; Elizabeth Q Starker; Arianne M Wilson; Michael R Emmert-Buck; Steven K Libutti; Michael A Tangrea
Journal:  Expert Rev Mol Diagn       Date:  2009-07       Impact factor: 5.225

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.